For decades, traditional drug discovery has used natural product and synthetic chemistry approaches to generate libraries of compounds, with some ending as promising drug candidates. A complementary approach has been to adopt the concept of biomimicry of natural products and metabolites so as to improve multiple drug-like features of the parent molecule. In this effort, promiscuous and weak interactions between ligands and receptors are often ignored in a drug discovery process. In this Emerging Concepts article, we highlight microbial metabolite mimicry, whereby parent metabolites have weak interactions with their receptors that then have led to discrete examples of more potent and effective drug-like molecules. We show specific examples of parent-metabolite mimics with potent effects in vitro and in vivo. Furthermore, we show examples of emerging microbial ligand-receptor interactions and provide a context in which these ligands could be improved as potential drugs. A balanced conceptual advance is provided in which we also acknowledge potential pitfalls-hyperstimulation of finely balanced receptor-ligand interactions could also be detrimental. However, with balance, we provide examples of where this emerging concept needs to be tested. SIGNIFICANCE STATEMENT: Microbial metabolite mimicry is a novel way to expand on the chemical repertoire of future drugs. The emerging concept is now explained using specific examples of the discovery of therapeutic leads from microbial metabolites.

Department of Cell Biology and Genetics Palacký University Olomouc Czech Republic

Zobrazit více v PubMed

Aa LX, Fei F, Qi Q, Sun RB, Gu SH, Di ZZ, Aa JY, Wang GJ, Liu CX. (2020) Rebalancing of the gut flora and microbial metabolism is responsible for the anti-arthritis effect of kaempferol. Acta Pharmacol Sin 41:73–81. PubMed PMC

Allen HK, Trachsel J, Looft T, Casey TA. (2014) Finding alternatives to antibiotics. Ann N Y Acad Sci 1323:91–100. PubMed

Altmann KH, Kinghorn AD, Mulzer JH, Höfle G, Müller R, Prantz K. (2009) The Epothilones: An Outstanding Family of Anti-Tumor Agents: From Soil to the Clinic, Springer, Vienna, Austria.

Aoki R, Aoki-Yoshida A, Suzuki C, Takayama Y. (2018) Indole-3-pyruvic acid, an aryl hydrocarbon receptor activator, suppresses experimental colitis in mice. J Immunol 201:3683–3693. PubMed

Bartolini D, De Franco F, Torquato P, Marinelli R, Cerra B, Ronchetti R, Schon A, Fallarino F, De Luca A, Bellezza G, et al. (2020) Garcinoic acid is a natural and selective agonist of pregnane X receptor. J Med Chem 63:3701–3712. PubMed PMC

Baxter NT, Schmidt AW, Venkataraman A, Kim KS, Waldron C, Schmidt TM. (2019) Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers. MBio 10:e02566-18. PubMed PMC

Bolognini D, Barki N, Butcher AJ, Hudson BD, Sergeev E, Molloy C, Moss CE, Bradley SJ, Le Gouill C, Bouvier M, et al. (2019) Chemogenetics defines receptor-mediated functions of short chain free fatty acids. Nat Chem Biol 15:489–498. PubMed

Campbell C, McKenney PT, Konstantinovsky D, Isaeva OI, Schizas M, Verter J, Mai C, Jin W-B, Guo C-J, Violante S, et al. (2020) Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature 581:475–479. PubMed PMC

Campbell JM, Crenshaw JD, Polo J. (2013) The biological stress of early weaned piglets. J Anim Sci Biotechnol 4:19. PubMed PMC

Chang Y-L, Rossetti M, Vlamakis H, Casero D, Sunga G, Harre N, Miller S, Humphries R, Stappenbeck T, Simpson KW, et al. (2019) A screen of Crohn’s disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunol 12:457–467. PubMed PMC

Chen J, Haller CA, Jernigan FE, Koerner SK, Wong DJ, Wang Y, Cheong JE, Kosaraju R, Kwan J, Park DD, et al. (2020) Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists. Sci Adv 6:eaay8230. PubMed PMC

Chen J, Zhao K-N, Vitetta L. (2019) Effects of intestinal microbial−elaborated butyrate on oncogenic signaling pathways. Nutrients 11:1026. PubMed PMC

Chen K, Arnold FH. (1993) Tuning the activity of an enzyme for unusual environments: sequential random mutagenesis of subtilisin E for catalysis in dimethylformamide. Proc Natl Acad Sci USA 90:5618–5622. PubMed PMC

Chen Z, Wang Z, Ren J, Qu X. (2018) Enzyme mimicry for combating bacteria and biofilms. Acc Chem Res 51:789–799. PubMed

Cohen LJ, Esterhazy D, Kim S-H, Lemetre C, Aguilar RR, Gordon EA, Pickard AJ, Cross JR, Emiliano AB, Han SM, et al. (2017) Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature 549:48–53. PubMed PMC

Colosimo DA, Kohn JA, Luo PM, Piscotta FJ, Han SM, Pickard AJ, Rao A, Cross JR, Cohen LJ, Brady SF. (2019) Mapping interactions of microbial metabolites with human G-protein-coupled receptors. Cell Host Microbe 26:273–282.e7. PubMed PMC

Corpe CP, Lee J-H, Kwon O, Eck P, Narayanan J, Kirk KL, Levine M. (2005) 6-Bromo-6-deoxy-L-ascorbic acid: an ascorbate analog specific for Na+-dependent vitamin C transporter but not glucose transporter pathways. J Biol Chem 280:5211–5220. PubMed

Cresci GA, Bush K, Nagy LE. (2014) Tributyrin supplementation protects mice from acute ethanol-induced gut injury. Alcohol Clin Exp Res 38:1489–1501. PubMed PMC

Cresci GA, Glueck B, McMullen MR, Xin W, Allende D, Nagy LE. (2017) Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. J Gastroenterol Hepatol 32:1587–1597. PubMed PMC

Demain AL, Sanchez S. (2009) Microbial drug discovery: 80 years of progress. J Antibiot (Tokyo) 62:5–16. PubMed PMC

Descamps HC, Herrmann B, Wiredu D, Thaiss CA. (2019) The path toward using microbial metabolites as therapies. EBioMedicine 44:747–754. PubMed PMC

Deshaies RJ. (2020) Multispecific drugs herald a new era of biopharmaceutical innovation. Nature 580:329–338. PubMed

Dobson PD, Patel Y, Kell DB. (2009) ‘Metabolite-likeness’ as a criterion in the design and selection of pharmaceutical drug libraries. Drug Discov Today 14:31–40. PubMed

Douglas AE. (2020) The microbial exometabolome: ecological resource and architect of microbial communities. Philos Trans R Soc Lond B Biol Sci 375:20190250. PubMed PMC

Dvořák Z, Kopp F, Costello CM, Kemp JS, Li H, Vrzalová A, Štěpánková M, Bartoňková I, Jiskrová E, Poulíková K, et al. (2020) Targeting the pregnane X receptor using microbial metabolite mimicry. EMBO Mol Med 12:e11621. PubMed PMC

Egorin MJ, Yuan ZM, Sentz DL, Plaisance K, Eiseman JL. (1999) Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Cancer Chemother Pharmacol 43:445–453. PubMed

Eun CS, Mishima Y, Wohlgemuth S, Liu B, Bower M, Carroll IM, Sartor RB. (2014) Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10-/- mice. Infect Immun 82:2239–2246. PubMed PMC

Falanga D, Kleber K, Scaramuzza D. (2020) Dynamic obstacle avoidance for quadrotors with event cameras. Sci Robot 5:eaaz9712. PubMed

Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP, Elisaf MS. (2008) Orlistat-associated adverse effects and drug interactions: a critical review. Drug Saf 31:53–65. PubMed

Folberth J, Begemann K, Jöhren O, Schwaninger M, Othman A. (2020) MS2 and LC libraries for untargeted metabolomics: enhancing method development and identification confidence. J Chromatogr B Analyt Technol Biomed Life Sci 1145:122105. PubMed

Fukumoto S, Toshimitsu T, Matsuoka S, Maruyama A, Oh-Oka K, Takamura T, Nakamura Y, Ishimaru K, Fujii-Kuriyama Y, Ikegami S, et al. (2014) Identification of a probiotic bacteria-derived activator of the aryl hydrocarbon receptor that inhibits colitis. Immunol Cell Biol 92:460–465. PubMed

Garcia SB, Barros LT, Turatti A, Martinello F, Modiano P, Ribeiro-Silva A, Vespúcio MV, Uyemura SA. (2006) The anti-obesity agent Orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen. Cancer Lett 240:221–224. PubMed

Gerth K, Bedorf N, Höfle G, Irschik H, Reichenbach H. (1996) Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties. J Antibiot (Tokyo) 49:560–563. PubMed

Gerth K, Bedorf N, Irschik H, Höfle G, Reichenbach H. (1994) The soraphens: a family of novel antifungal compounds from Sorangium cellulosum (Myxobacteria). I. Soraphen A1 alpha: fermentation, isolation, biological properties. J Antibiot (Tokyo) 47:23–31. PubMed

Gerth K, Pradella S, Perlova O, Beyer S, Müller R. (2003) Myxobacteria: proficient producers of novel natural products with various biological activities--past and future biotechnological aspects with the focus on the genus Sorangium. J Biotechnol 106:233–253. PubMed

Gillis CC, Hughes ER, Spiga L, Winter MG, Zhu W, Furtado de Carvalho T, Chanin RB, Behrendt CL, Hooper LV, Santos RL, et al. (2018) Dysbiosis-associated change in host metabolism generates lactate to support Salmonella growth. Cell Host Microbe 23:54–64.e6. PubMed PMC

Gioiello A, Cerra B, Mostarda S, Guercini C, Pellicciari R, Macchiarulo A. (2014) Bile acid derivatives as ligands of the farnesoid x receptor: molecular determinants for bile acid binding and receptor modulation. Curr Top Med Chem 14:2159–2174. PubMed

Gioiello A, Piccinno A, Lozza AM, Cerra B. (2020) The medicinal chemistry in the era of machines and automation: recent advances in continuous flow technology. J Med Chem 63:6624–6647. PubMed PMC

Goldschmidt F, Regoes RR, Johnson DR. (2018) Metabolite toxicity slows local diversity loss during expansion of a microbial cross-feeding community. ISME J 12:136–144. PubMed PMC

Gómez-Betancur I, Zhao J, Tan L, Chen C, Yu G, Rey-Suárez P, Preciado L. (2019) Bioactive compounds isolated from marine bacterium Vibrio neocaledonicus and their enzyme inhibitory activities. Mar Drugs 17:401. PubMed PMC

Haag LM, Siegmund B. (2014) Exploring & exploiting our ‘other self’ - does the microbiota hold the key to the future therapy in Crohn’s? Best Pract Res Clin Gastroenterol 28:399–409. PubMed

Hargroves K, Smith M. (2006) Innovation inspired by nature: Biomimicry. Ecos 129:27–29.

Híreš M, Rapavá N, Šimkovič M, Varečka Ľ, Berkeš D, Kryštofová S. (2018) Development and optimization of a high-throughput screening assay for rapid evaluation of lipstatin production by Streptomyces strains. Curr Microbiol 75:580–587. PubMed

Hoofnagle JH. (2020) FXR agonists as therapy for liver disease. Hepatology 72:1–3. PubMed

Hu C, Chen Y, Tan MJA, Ren K, Wu H. (2019) Microfluidic technologies for vasculature biomimicry. Analyst (Lond) 144:4461–4471. PubMed

Hu J, Ma L, Nie Y, Chen J, Zheng W, Wang X, Xie C, Zheng Z, Wang Z, Yang T, et al. (2018) A microbiota-derived bacteriocin targets the host to confer diarrhea resistance in early-weaned piglets. Cell Host Microbe 24:817–832.e8. PubMed

Husted AS, Trauelsen M, Rudenko O, Hjorth SA, Schwartz TW. (2017) GPCR-mediated signaling of metabolites. Cell Metab 25:777–796. PubMed

Jayaraj S, Suresh S, Kadeppagari R-K. (2013) Amylase inhibitors and their biomedical applications. Starke 65:535–542.

Jiang W, Sunkara LT, Zeng X, Deng Z, Myers SM, Zhang G. (2013) Differential regulation of human cathelicidin LL-37 by free fatty acids and their analogs. Peptides 50:129–138. PubMed

Jin UH, Cheng Y, Park H, Davidson LA, Callaway ES, Chapkin RS, Jayaraman A, Asante A, Allred C, Weaver EA, et al. (2017) Short chain fatty acids enhance aryl hydrocarbon (Ah) responsiveness in mouse colonocytes and caco-2 human colon cancer cells. Sci Rep 7:10163. PubMed PMC

Kaiko GE, Ryu SH, Koues OI, Collins PL, Solnica-Krezel L, Pearce EJ, Pearce EL, Oltz EM, Stappenbeck TS. (2016) The colonic crypt protects stem cells from microbiota-derived metabolites. Cell 165:1708–1720. PubMed PMC

Kawai S, Iijima H, Shinzaki S, Hiyama S, Yamaguchi T, Araki M, Iwatani S, Shiraishi E, Mukai A, Inoue T, et al. (2017) Indigo Naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation. J Gastroenterol 52:904–919. PubMed

Khalil H, Ellwood L, Lord H, Fernandez R. (2020) Pharmacological treatment for obesity in adults: an umbrella review. Ann Pharmacother 54:691–705. PubMed

Kim CH. (2018) Immune regulation by microbiome metabolites. Immunology 154:220–229. PubMed PMC

Koh A, Molinaro A, Ståhlman M, Khan MT, Schmidt C, Mannerås-Holm L, Wu H, Carreras A, Jeong H, Olofsson LE, et al. (2018) Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell 175:947–961.e17. PubMed

Korecka A, Dona A, Lahiri S, Tett AJ, Al-Asmakh M, Braniste V, D’Arienzo R, Abbaspour A, Reichardt N, Fujii-Kuriyama Y, et al. (2016) Bidirectional communication between the Aryl hydrocarbon Receptor (AhR) and the microbiome tunes host metabolism. NPJ Biofilms Microbiomes 2:16014. PubMed PMC

Lallès J-P, Bosi P, Smidt H, Stokes CR. (2007) Nutritional management of gut health in pigs around weaning. Proc Nutr Soc 66:260–268. PubMed

Lambert MA, Moss CW. (1980) Production of p-hydroxyhydrocinnamic acid from tyrosine by Peptostreptococcus anaerobius. J Clin Microbiol 12:291–293. PubMed PMC

Lewis K. (2020) The science of antibiotic discovery. Cell 181:29–45. PubMed

Li J, Ren J, Sun W. (2017) Systematic review of ixabepilone for treating metastatic breast cancer. Breast Cancer 24:171–179. PubMed

Lilja EE, Johnson DR. (2017) Metabolite toxicity determines the pace of molecular evolution within microbial populations. BMC Evol Biol 17:52. PubMed PMC

Lu Q, Yang YT, Chen CS, Davis M, Byrd JC, Etherton MR, Umar A, Chen CS. (2004) Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors. J Med Chem 47:467–474. PubMed

Mahmood N. (2016) A review of α-amylase inhibitors on weight loss and glycemic control in pathological state such as obesity and diabetes. Comp Clin Pathol 25:1253–1264.

Markham A, Keam SJ. (2016) Obeticholic acid: first global approval. Drugs 76:1221–1226. PubMed

Molnár I, Schupp T, Ono M, Zirkle R, Milnamow M, Nowak-Thompson B, Engel N, Toupet C, Stratmann A, Cyr DD, et al. (2000) The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum So ce90. Chem Biol 7:97–109. PubMed

Mondanelli G, Coletti A, Greco FA, Pallotta MT, Orabona C, Iacono A, Belladonna ML, Albini E, Panfili E, Fallarino F, et al. (2020) Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation. Proc Natl Acad Sci USA 117:3848–3857. PubMed PMC

Muku GE, Murray IA, Espín JC, Perdew GH. (2018) Urolithin A is a dietary microbiota-derived human aryl hydrocarbon receptor antagonist. Metabolites 8:86. PubMed PMC

Natividad JM, Agus A, Planchais J, Lamas B, Jarry AC, Martin R, Michel ML, Chong-Nguyen C, Roussel R, Straube M, et al. (2018) Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome. Cell Metab 28:737–749.e4. PubMed

Nuzzo A, Brown JR. (2020) Microbiome metabolite mimics accelerate drug discovery. Trends Mol Med 26:435–437. PubMed

Nyangale EP, Mottram DS, Gibson GR. (2012) Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J Proteome Res 11:5573–5585. PubMed

Offermanns S. (2017) Hydroxy-carboxylic acid receptor actions in metabolism. Trends Endocrinol Metab 28:227–236. PubMed

O’Keefe SJ. (2016) Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol 13:691–706. PubMed PMC

Pein H, Ville A, Pace S, Temml V, Garscha U, Raasch M, Alsabil K, Viault G, Dinh CP, Guilet D, et al. (2018) Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase. Nat Commun 9:3834. PubMed PMC

Pellicciari R, Fiorucci S, Camaioni E, Clerici C, Costantino G, Maloney PR, Morelli A, Parks DJ, Willson TM. (2002) 6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. J Med Chem 45:3569–3572. PubMed

Pellicciari R, Pruzanski M, Gioiello A. (2018) The Discovery of Obeticholic Acid (OcalivaTM): First‐in‐Class FXR Agonist, in Successful Drug Discovery, Volume 3 (Fischer J, Klein C, Childers W. eds) pp 197–244, Wiley‐VCH Verlag GmbH & Co. KGaA, Weinheim.

Pernomian L, Duarte-Silva M, de Barros Cardoso CR. (2020) The Aryl Hydrocarbon Receptor (AHR) as a potential target for the control of intestinal inflammation: insights from an immune and bacteria sensor receptor. Clin Rev Allergy Immunol DOI: 10.1007/s12016-020-08789-3 [published ahead of print]. PubMed

Priyadarshini M, Kotlo KU, Dudeja PK, Layden BT. (2018) Role of short chain fatty acid receptors in intestinal physiology and pathophysiology. Compr Physiol 8:1091–1115. PubMed PMC

Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al. MetaHIT Consortium (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65. PubMed PMC

Quinn RA, Melnik AV, Vrbanac A, Fu T, Patras KA, Christy MP, Bodai Z, Belda-Ferre P, Tripathi A, Chung LK, et al. (2020) Global chemical effects of the microbiome include new bile-acid conjugations. Nature 579:123–129. PubMed PMC

Rachid S, Gerth K, Kochems I, Müller R. (2007) Deciphering regulatory mechanisms for secondary metabolite production in the myxobacterium Sorangium cellulosum So ce56. Mol Microbiol 63:1783–1796. PubMed

Ran L, Liu AB, Lee MJ, Xie P, Lin Y, Yang CS. (2019) Effects of antibiotics on degradation and bioavailability of different vitamin E forms in mice. Biofactors 45:450–462. PubMed

Roager HM, Licht TR. (2018) Microbial tryptophan catabolites in health and disease. Nat Commun 9:3294. PubMed PMC

Roager HM, Sulek K, Skov K, Frandsen HL, Smedsgaard J, Wilcks A, Skov TH, Villas-Boas SG, Licht TR. (2014) Lactobacillus acidophilus NCFM affects vitamin E acetate metabolism and intestinal bile acid signature in monocolonized mice. Gut Microbes 5:296–303. PubMed PMC

Rogala AR, Oka A, Sartor RB. (2020) Strategies to dissect host-microbial immune interactions that determine mucosal homeostasis vs. intestinal inflammation in gnotobiotic mice. Front Immunol 11:214. PubMed PMC

Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L, Chao CC, Patel B, Yan R, Blain M, et al. (2016) Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 22:586–597. PubMed PMC

Russell WR, Labat A, Scobbie L, Duncan SH. (2007) Availability of blueberry phenolics for microbial metabolism in the colon and the potential inflammatory implications. Mol Nutr Food Res 51:726–731. PubMed

Saeui CT, Liu L, Urias E, Morrissette-McAlmon J, Bhattacharya R, Yarema KJ. (2018) Pharmacological, physiochemical, and drug-relevant biological properties of short chain fatty acid hexosamine analogues used in metabolic glycoengineering. Mol Pharm 15:705–720. PubMed PMC

Saha S, Rajpal DK, Brown JR. (2016) Human microbial metabolites as a source of new drugs. Drug Discov Today 21:692–698. PubMed

Schoefer L, Mohan R, Schwiertz A, Braune A, Blaut M. (2003) Anaerobic degradation of flavonoids by Clostridium orbiscindens. Appl Environ Microbiol 69:5849–5854. PubMed PMC

Sender R, Fuchs S, Milo R. (2016) Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 14:e1002533. PubMed PMC

Singh R, Chandrashekharappa S, Bodduluri SR, Baby BV, Hegde B, Kotla NG, Hiwale AA, Saiyed T, Patel P, Vijay-Kumar M, et al. (2019) Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat Commun 10:89. PubMed PMC

Skelly AN, Sato Y, Kearney S, Honda K. (2019) Mining the microbiota for microbial and metabolite-based immunotherapies. Nat Rev Immunol 19:305–323. PubMed

Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:569–573. PubMed PMC

Sofyana NT, Zheng J, Manabe Y, Yamamoto Y, Kishino S, Ogawa J, Sugawara T. (2020) Gut microbial fatty acid metabolites (KetoA and KetoC) affect the progression of nonalcoholic steatohepatitis and reverse cholesterol transport metabolism in mouse model. Lipids 55:151–162. PubMed

Sonowal R, Swimm A, Sahoo A, Luo L, Matsunaga Y, Wu Z, Bhingarde JA, Ejzak EA, Ranawade A, Qadota H, et al. (2017) Indoles from commensal bacteria extend healthspan. Proc Natl Acad Sci USA 114:E7506–E7515. PubMed PMC

Stampfer L, Deutschmann A, Dür E, Eitelberger FG, Fürpass T, Gorkiewicz G, Heinz-Erian P, Heller I, Herzog K, Hopfer B, et al. (2017) Causes of hematochezia and hemorrhagic antibiotic-associated colitis in children and adolescents. Medicine (Baltimore) 96:e7793. PubMed PMC

Steed AL, Christophi GP, Kaiko GE, Sun L, Goodwin VM, Jain U, Esaulova E, Artyomov MN, Morales DJ, Holtzman MJ, et al. (2017) The microbial metabolite desaminotyrosine protects from influenza through type I interferon. Science 357:498–502. PubMed PMC

Tang L, Qiu RG, Li Y, Katz L. (2003) Generation of novel epothilone analogs with cytotoxic activity by biotransformation. J Antibiot (Tokyo) 56:16–23. PubMed

Tang L, Shah S, Chung L, Carney J, Katz L, Khosla C, Julien B. (2000) Cloning and heterologous expression of the epothilone gene cluster. Science 287:640–642. PubMed

Tikhonova IG. (2017) Application of GPCR structures for modelling of free fatty acid receptors. Handb Exp Pharmacol 236:57–77. PubMed

Torquato P, Marinelli R, Bartolini D, Giusepponi D, Cruciani G, Siragusa L, Galarini R, Sebastiani B, Gioiello A, Galli F. (2020) Vitamin E: metabolism and molecular aspects, in Molecular Nutrition (Patel VB. ed) pp 487–518, Academic Press, Cambridge.

Tunaru S, Lättig J, Kero J, Krause G, Offermanns S. (2005) Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G). Mol Pharmacol 68:1271–1280. PubMed

van de Laar FA, Lucassen PL, Akkermans RP, van de Lisdonk EH, Rutten GE, van Weel C. (2005) Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care 28:154–163. PubMed

van Duynhoven J, Vaughan EE, Jacobs DM, Kemperman RA, van Velzen EJJ, Gross G, Roger LC, Possemiers S, Smilde AK, Doré J, et al. (2011) Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci 108 (Suppl 1):4531–4538. PubMed PMC

Venkatesh M, Mukherjee S, Wang H, Li H, Sun K, Benechet AP, Qiu Z, Maher L, Redinbo MR, Phillips RS, et al. (2014) Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity 41:296–310. PubMed PMC

von Tesmar A, Hoffmann M, Abou Fayad A, Hüttel S, Schmitt V, Herrmann J, Müller R. (2018) Biosynthesis of the Klebsiella oxytoca pathogenicity factor tilivalline: heterologous expression, in vitro biosynthesis, and inhibitor development. ACS Chem Biol 13:812–819. PubMed

Vyhlídalová B, Krasulová K, Pečinková P, Marcalíková A, Vrzal R, Zemánková L, Vančo J, Trávníček Z, Vondráček J, Karasová M, et al. (2020) Gut microbial catabolites of tryptophan are ligands and agonists of the aryl hydrocarbon receptor: a detailed characterization. Int J Mol Sci 21:2614. PubMed PMC

Wang Y, Russo TA, Kwon O, Chanock S, Rumsey SC, Levine M. (1997) Ascorbate recycling in human neutrophils: induction by bacteria. Proc Natl Acad Sci USA 94:13816–13819. PubMed PMC

Windey K, De Preter V, Verbeke K. (2012) Relevance of protein fermentation to gut health. Mol Nutr Food Res 56:184–196. PubMed

Wlodarska M, Luo C, Kolde R, d’Hennezel E, Annand JW, Heim CE, Krastel P, Schmitt EK, Omar AS, Creasey EA, et al. (2017) Indoleacrylic acid produced by commensal Peptostreptococcus species suppresses inflammation. Cell Host Microbe 22:25–37.e6. PubMed PMC

Wood J. (2019) Bioinspiration in fashion-a review. Biomimetics (Basel) 4:16. PubMed PMC

Yang X, Xie L, Li Y, Wei C. (2009) More than 9,000,000 unique genes in human gut bacterial community: estimating gene numbers inside a human body. PLoS One 4:e6074. PubMed PMC

Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, Zecchi R, D’Angelo C, Massi-Benedetti C, Fallarino F, et al. (2013) Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39:372–385. PubMed

Microbial Metabolites as Ligands to Xenobiotic Receptors: Chemical Mimicry as Potential Drugs of the Future

Deciphering structural bases of intestinal and hepatic selectivity in targeting pregnane X receptor with indole-based microbial mimics